All News
Filter News
Found 806,265 articles
-
Champions Oncology, Inc. Clarifies Misstatements in News Article
7/18/2011
-
CardioGenics Holdings Inc. Presentation Now Available for On-Demand Viewing at RetailInvestorConferences.com
7/18/2011
-
CSL Behring Donates von Willebrand Factor / Factor VIII Donation to World Federation of Hemophilia
7/18/2011
-
GlaxoSmithKline Pledges $10 million at White House Meeting on US Education Reform
7/18/2011
-
New Grant Supports Hastings Work on Ethics of Medical Research with Animals
7/18/2011
-
Pilgrim Software Launches New 2012 User Conference Website
7/18/2011
-
Frost & Sullivan: Computerised Physician Order Entry Systems Market to Piggyback on the Adoption of e-health Techniques in Europe
7/18/2011
-
American Scientific Resources Inc. Signs Israeli Distributor
7/18/2011
-
New Release of Elekta's Monaco Treatment Planning System Prepares Software for Stereotactic Radiation Therapy
7/18/2011
-
Health Robotics Extends 100% IV Robot Winning Streak to 18 Months, Reaching 200 Global Installations Under Contract
7/18/2011
-
Enigma Diagnostics Announces Successful Completion of EU Framework 7 "RANGER" Project
7/18/2011
-
China Takes Dramatic Step to Curb TCM Speculation
7/18/2011
-
The Week in Review: Will Novartis AG IPO in Shanghai?
7/18/2011
-
PhotoMedex, Inc.'s 'Itching to Win' Contest Offers Free Phototherapy Treatments With the XTRAC Laser to Deserving Psoriasis Patients Nationwide
7/18/2011
-
The Leukemia & Lymphoma Society Awards Two Major Grants to Researchers at Harvard University and Cambridge University
7/18/2011
-
InVivo Therapeutics Corporation Congratulates Robert S. Langer as the Recipient of the American Chemical Society’s Priestley Medal
7/18/2011
-
Accelr8 Technology Corporation to Receive Award for ICAAC Presentation
7/18/2011
-
Eli Lilly and Company Release: Florbetapir "Imaging to Autopsy" Study Awarded Alzheimer's Association's 2011 de Leon Prize in Neuroimaging
7/18/2011
-
Revolutions Medical Corporation to Exhibit in the 141st American Correctional Association Conference
7/18/2011
-
Transition Therapeutics Inc. Announces ELND005 Phase 2 Clinical Trial Data to be Presented at the International Conference of Alzheimer's Disease (ICAD) Meeting
7/18/2011